WELLINGTON MANAGEMENT GROUP LLP - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 250 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$462,157
-49.2%
101,573
-21.4%
0.00%
Q2 2023$909,568
-3.6%
129,200
-16.4%
0.00%
Q1 2023$943,909
-65.0%
154,486
-63.4%
0.00%
-100.0%
Q4 2022$2,694,088
-82.8%
421,610
-74.3%
0.00%
-66.7%
Q3 2022$15,706,000
+6.6%
1,639,535
+22.9%
0.00%0.0%
Q2 2022$14,728,000
-92.2%
1,334,062
-88.2%
0.00%
-90.6%
Q1 2022$187,957,000
+2.7%
11,288,726
+17.8%
0.03%
+10.3%
Q4 2021$182,959,000
-16.6%
9,584,082
+7.7%
0.03%
-21.6%
Q3 2021$219,462,000
+16.3%
8,899,530
+22.7%
0.04%
+19.4%
Q2 2021$188,677,000
-17.8%
7,251,243
+0.0%
0.03%
-22.5%
Q1 2021$229,460,000
-11.9%
7,247,657
+29.1%
0.04%
-16.7%
Q4 2020$260,394,000
+1122.0%
5,611,932
+767.0%
0.05%
+1100.0%
Q3 2020$21,309,000
+19.5%
647,310
-0.3%
0.00%0.0%
Q2 2020$17,827,000
-66.4%
649,432
-63.4%
0.00%
-71.4%
Q1 2020$53,116,000
-20.2%
1,774,372
-26.2%
0.01%0.0%
Q4 2019$66,535,000
+218.3%
2,403,704
+109.3%
0.01%
+180.0%
Q3 2019$20,905,000
+120.1%
1,148,635
+196.5%
0.01%
+150.0%
Q2 2019$9,498,000
+1074.0%
387,377
+512.6%
0.00%
Q2 2018$809,000
-33.3%
63,237
-11.9%
0.00%
Q1 2018$1,213,00071,7850.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,674,299$65,948,0005.28%
Ghost Tree Capital, LLC 700,000$17,262,0005.05%
Perceptive Advisors 11,489,772$283,337,0004.12%
Prosight Management, LP 274,761$6,776,0003.73%
Fairmount Funds Management LLC 389,588$9,607,0003.49%
Avoro Capital Advisors LLC 8,500,000$209,610,0003.29%
ACUTA CAPITAL PARTNERS, LLC 374,495$9,235,0003.26%
Ally Bridge Group (NY) LLC 406,986$10,036,0002.95%
Parametrica Management Ltd 146,362$3,609,0002.70%
COMMODORE CAPITAL LP 362,869$8,948,0002.36%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders